Literature DB >> 7674525

Prevalence and incidence of vertically acquired HIV infection in the United States.

S F Davis1, R H Byers, M L Lindegren, M B Caldwell, J M Karon, M Gwinn.   

Abstract

OBJECTIVE: To estimate human immunodeficiency virus (HIV) type I prevalence among childbearing women, HIV incidence in infants, and the number of children living with HIV infection and acquired immunodeficiency syndrome as a result of transmission from mother to infant (vertical transmission).
DESIGN: The national HIV serosurvey of childbearing women was used to estimate the incidence of vertically acquired HIV infection in children born between 1988 and 1993. Data from the national acquired immunodeficiency syndrome case surveillance system and a multicenter pediatric HIV surveillance project were modeled to estimate incidence in children born between 1978 and 1987.
SETTING: Surveillance conducted by the Centers for Disease Control and Prevention, Atlanta, Ga, in collaboration with state and local health departments.
RESULTS: Approximately 14,920 HIV-infected infants were born in the United States between 1978 and 1993. Of these, an estimated 12,240 children were living at the beginning of 1994; 26% were younger than 2 years, 35% were aged 2 to 4 years, and 39% were aged 5 years or older. Approximately 6530 HIV-infected women gave birth in the United States in 1993, and, based on a 25% vertical transmission rate, an estimated 1630 of their infants were HIV infected.
CONCLUSIONS: These results provide a basis for estimating medical and other resource needs for HIV-infected women and their children and for measuring the impact of interventions to reduce vertical transmission of HIV.

Entities:  

Mesh:

Year:  1995        PMID: 7674525

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States.

Authors:  Steven R Nesheim; Lauren F FitzHarris; Margaret A Lampe; Kristen Mahle Gray
Journal:  Public Health Rep       Date:  2018-09-28       Impact factor: 2.792

2.  Perinatal Antiretroviral Exposure and Prevented Mother-to-child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.

Authors:  Kristen M Little; Allan W Taylor; Craig B Borkowf; Maria C B Mendoza; Margaret A Lampe; Paul J Weidle; Steven R Nesheim
Journal:  Pediatr Infect Dis J       Date:  2017-01       Impact factor: 2.129

3.  Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.

Authors:  R D Gorsky; P G Farnham; W L Straus; B Caldwell; D R Holtgrave; R J Simonds; M F Rogers; M E Guinan
Journal:  Public Health Rep       Date:  1996 Jul-Aug       Impact factor: 2.792

4.  HIV-infected parents and their children in the United States.

Authors:  M A Schuster; D E Kanouse; S C Morton; S A Bozzette; A Miu; G B Scott; M F Shapiro
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

5.  The effect of prophylaxis on pediatric HIV costs.

Authors:  Leslie S Wilson; Lori Hensic; Carly J Paoli; Rituparna Basu; Maria Christenson; Judith T Moskowitz; Diane Wara
Journal:  AIDS Care       Date:  2011-07-25

6.  Is There a Higher Risk of Mother-to-child Transmission of HIV Among Pregnant Women With Perinatal HIV Infection?

Authors:  Christopher J Goodenough; Kunjal Patel; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

7.  Incidence of human immunodeficiency virus antibody in a prenatal population at a community hospital.

Authors:  T S Alexander; J Lee; B Yen-Lieberman
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

Review 8.  Engaging HIV care providers in conversations with their reproductive-age patients about fertility desires and intentions: a historical review of the HIV epidemic in the United States.

Authors:  Riley J Steiner; Sarah Finocchario-Kessler; Jacinda K Dariotis
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

9.  Brief Report: Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978-2013.

Authors:  Steven R Nesheim; Jeffrey Wiener; Lauren F Fitz Harris; Margaret A Lampe; Paul J Weidle
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

10.  Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children.

Authors:  W Hughes; J A McDowell; J Shenep; P Flynn; M W Kline; R Yogev; W Symonds; Y Lou; S Hetherington
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.